InVitro International | Income Statement
Fiscal year is October-September. All values USD Thousands.
2015
2016
2017
2018
Sales/Revenue
994.70
884.20
855.60
846.30
Cost of Goods Sold (COGS) incl. D&A
190.20
188.00
158.00
157.30
Gross Income
804.50
696.20
697.70
689.10
SG&A Expense
578.40
588.50
659.70
647.30
EBIT
226.20
107.70
37.90
41.70
Non Operating Income/Expense
2.90
1.60
2.20
3
Pretax Income
232.90
118.40
48.70
58
Income Tax
0.80
4.50
0.80
1.60
Consolidated Net Income
232.10
122.90
47.80
56.40
Net Income
232.10
122.90
47.80
56.40
Net Income After Extraordinaries
232.10
122.90
47.80
56.40
Net Income Available to Common
232.10
122.90
47.80
56.40
EPS (Basic)
0.01
0.01
0.00
-
Basic Shares Outstanding
21,954.00
21,954.00
21,954.00
21,985.60
EPS (Diluted)
0.01
0.01
0.00
-
Diluted Shares Outstanding
21,954.00
21,954.00
21,954.00
21,985.60
EBITDA
244.20
126.20
54.90
56.60
Non-Operating Interest Income
9.60
9.10
8.60
13.20
About InVitro International
View Profile
